Enteric-Coated Mycophenolate Sodium Experience in Liver Transplant Patients

Transplantation Proceedings

Volumn 38, Issue 3, 2006, Pages 932-933

  Cantisani, G P C ^a   Zanotelli, M L ^a   Gleisner, A L M ^a   de Mello Brandao A ^a   Marroni, C A ^a  

^a Santa Casa de Porto Alegre   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMETABOLITE; CALCINEURIN INHIBITOR; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TRIACYLGLYCEROL;

ABDOMINAL PAIN; ADULT; ANEMIA; ANOREXIA; ARTICLE; BACTERIAL INFECTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; ENTERIC COATED TABLET; FEMALE; GASTROINTESTINAL SYMPTOM; HEMATOLOGIC DISEASE; HUMAN; KIDNEY DYSFUNCTION; LEUKOPENIA; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MYCOSIS; NAUSEA; PRIORITY JOURNAL; RECIPIENT; TRIACYLGLYCEROL BLOOD LEVEL; VOMITING;

BACTERIAL INFECTIONS; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; TABLETS, ENTERIC-COATED;

EID: 33646481352     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.02.036     Document Type: Article

References (7)

1. Detry O., Roover de A., Delwaide J., et al. The use of mycophenolate mofetil in liver transplant recipients. Expert Opinion on Pharmacotherapy 4 (2003) 1949
2. Budde K., Glander P., Diekmann F., et al. Enteric-coated mycophenolata sodium. safe conversion from mycophenolate mofetil in maintenance renal transplant recipients. Transplant Proc 36 suppl (2004) 524S
3. Sollinger H. Enteric-coated mycophenolata sodium therapeutic equivalence to mycophenolate mofetil in de novo renal transplant patients. Transplant Proc 36 suppl (2004) 517S
4. Budde K., Curtis J., Knoll G., et al. Enteric-coated mycophenolata sodium can be safely administered in maintenance renal transplant patients. results of a 1-year study. American Journal Transplantation 4 (2003) 237
5. Salvadori M., Holzer H., de Mattos A., et al. Enteric-coated mycophenolata sodium is therapeutically equivalent to mycophenolate mophetil in de novo renal transplant patients. American Journal Transplantation 4 (2004) 231
6. Abbud-Filho M., Giron F., Hernandez E., et al. Stable renal transplant recipients can be safely converted from MMF to enteric-coated mycophenolata sodium tablets. interim results of a multicenter Latin American Staudy. Transplant Proc 3 (2004) 1647
7. Villamil G.A., Galdame A.O., Bandi C.J., et al. Tolerability to the conversion to mycophenolate sodium in liver transplant recipients with mycophenolate mophetil discontinuation for severe gastrointestinal effects. American Journal Transplantation 5 (2005) 476 Abstract #1254